NIVOLUMAB, TEDOPI
COMBI-TED
Phase 2 small_molecule active
Quick answer
NIVOLUMAB, TEDOPI for metastatic non-small-cell lung cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- metastatic non-small-cell lung cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active